In recent years, the World Health Organization listed Psoriasis as a serious public health concern with at least 100 million individuals affected worldwide. Psoriasis a chronic autoimmune skin disease that speeds up the growth cycle of skin cells, producing scales. Inflammation and redness, develop around the scales, which often crack and bleed. This condition may be triggered by environmental and genetic factors. Changing lifestyles of people are leading to increased alcohol consumption and smoking, unhealthy diet, and sedentary living, which make people more prone to this condition. Everyone is at potential risk – even you.
An International Federation of Psoriasis Association report indicates roughly 5.0% of people are afflicted with one or more forms of Psoriasis worldwide. Nearly 7.5 million people are affected by this condition in the U.S. alone. These patients represent approximately 2.0% of the population. Moreover, at least 100,000 new cases are registered and reported every year. A GrandViewResearch Report estimates the global Psoriasis drugs market size was valued at $11.3 billion in 2016. It is anticipated to post a compounded growth rate of 9.4% during the forecast period. A recent report by Transparency Market Research on the global Psoriasis treatment market estimates that it will attain a worth of U.S. $12.1 billion by 2024. Increasing awareness regarding treatment and rising demand for improved healthcare infrastructure are among the primary growth stimulants for the market. This rising incidence of Psoriasis is fueling demand globally for innovative viable treatments.
Our team of experts has spent over 300 hours analyzing online brokers. Click HERE to compare online brokers!
There is no permanent cure and current treatments only relieve the symptoms of these diseases. Treatments aim to reduce inflammation and scales, slow the growth of skin cells, and remove plaques. Topical ointments (creams) and drugs are the common treatment. The high cost of Psoriasis treatments, extensive drug development, and approval process are hindering the growth of global Psoriasis drugs market.
Perhaps the Biotech companies and FDA are not looking in the right spot. Many feel the drug companies want us to stay sick so they can keep profiting. Imagine there was a natural solution to these dreaded diseases. Picture a world where one compound could treat this and multiple diseases with minimal side effects. Wouldn’t that be amazing?
This Company Could Be The Answer
Read more here, https://www.smallcapstocks.com/ip/?=ps
GENERAL NOTICE AND DISCLAIMER – PLEASE READ CAREFULLY. We are engaged in the business of marketing and advertising companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. If you use, act upon or make decisions in reliance on information contained in any disseminated report/release or any hyperlink, you do so at your own risk and agree to hold us, our officers, directors, shareholders, affiliates and agents harmless. You acknowledge that you are not relying on us, and we are not liable for, any actions taken by you based on any information contained in any disseminated email or hyperlink. You also acknowledge that we are not an investment advisory service, a broker-dealer or an investment adviser. You acknowledge that you will consult with your own advisers regarding any decisions as to any company mentioned here. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Owners and operators have been compensated sixteen thousand dollars cash via bank wire, earned upon receipt, for the distribution of our opinions and publicly available information for OWCP by Hanover Financial Services on 11/21/18. By your subscription to our website, the viewing of this profile and/or use of our website, you have agreed and acknowledged the terms of our full disclaimer which can be read at any time at www.SmallCapStocks.com/Disclaimer.